Smera AKTÜRK, Raikan BÜYÜKAVCI, Yüksel ERSOY, Hüseyin ÇOLAK

Investigating the effectiveness of artcure transdermal diffusional patch in patients with cervical disc herniation: A randomized placebo-controlled study

This study aims to investigate the effectiveness of Artcure Diffusional Transdermal Patch treatment on pain and functional status in patients with cervical disc herniation. A total of 48 patients (15 males, 33 females; mean age 48 years; range 20 to 60 years) who were diagnosed with cervical disc herniation were included in this doubleblind, randomized, placebo-controlled study. Participants were randomized into 2 groups. Artcure Transdermal Patch was implemented in the 1st Group, and a placebo transdermal patch was given to the 2nd Group. Artcure and placebo patches were applied once to both patient groups, remaining for 24 hours as was recommended in their usages. All individuals were examined at the onset, in the 4th week, and the 12th week. Visual Analog Scale (VAS) was used to evaluate pain, neuropathic pain intensity was measured using the Leeds Assessment of Neuropathic Symptoms and Signs Scales (LANSS), and the functional level was measured by the Neck Pain and Disability Scale (NPDS). It was determined that the pain level decreased, neuropathic symptoms reduced, and functional level improved compared to initial parameters in the diffusional transdermal patch group. There were significant differences among the groups in the 4th and 12th weeks concerning pain, neuropathic symptoms, and functional status, and it was also determined that this difference was conspicuous in the transdermal diffusional patch group. Based on these data, Artcure Diffusional Patch may be an alternative for conservative treatment of patients with cervical disc herniation.

PDF

___

1. Richardson SM. Intervertebral disc biology, degeneration, and novel tissue engineering and regenerative medicine therapies. Histol Histopathol. 2007;22:1033-41.
2. Pierre C, Milette MD. Classification, diagnostic imaging, and imaging characterization of a lumbar herniated disc. Radiol Clin North Am. 2000;38:1267-92.
3. Sekellaridis N. Influence of diabetes mellitus on cervical intervertebral disc herniation. Clin Neural Neurosurg. 2008;110:810-2.
4. Erman T, Cetinalp E. Pathogenesis in cervical disc disease. In: Turkish Neurosurgery Society Spinal and Peripheral Nerve Surgery Teaching and Training Group Publications. 2009;9:31-40.
5. Apelyan A. The Efficiency of Muscle Relaxation Training with Biofeedback in Neck Pain. Institute of Health Sciences, Master Thesis. Istanbul 2002.
6. Kang L, Yap CW, Lim PF, et al. Formulation development of transdermal dosage forms: Quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin. J Control Release. 2007;120:211-9.
7. Ugurlu M, Aksekili MAE, Alkan BM, et al. Effects of Artcure Diffusional Patch application on pain and functional status in lumbar disc herniation patients: a prospective randomized controlled study. Turk J Med Sci. 2017;47:874-82.
8. Price DD, McGrath PA, Rafii A, et al. The validation of visual analog scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56.
9. Bicer A, Yazici A, Camdeviren H, et al. Assessment of pain and disability in patients with chronic neck pain: reliability and construct validity of the Turkish version of the neck pain and disability scale. Disabil Rehabil. 2004;26:959-62.
10. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147-57.
11. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoidterpenoid Entourage effects. Br J Pharmacol. 2011;163:1344-64.
12. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils: A review. Food Chem Toxicol. 2008;46:446-75.
13. Urban JP, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5:120-30.
14. Freemont AJ, Watkins A, Le Maitre C, et al. Current understanding of cellular and molecular events in intervertebral disc degeneration: Implications for therapy. J Pathol. 2002;196:374-9.
15. Urban JPG, Hall AC, Gehl KA. Regulation of matrix synthesis rates by the ionic and Osmotic environment of articular chondrocytes. J Cell Physiol. 1993;154:262-70.
16. Vernon-Roberts B, Moore RJ, Fraser RD. The natural history of agerelated disc degeneration: the pathology and sequelae of tears. Spine. 2007;32:2797-804.
17. Seiji Ohtori, Gen Inoue, Sumihisa Orita, et al. Transdermal fentanyl for chronic low back pain. Yonsei Med J. 2012;53:788.
18. Inal O, Algin Yapar E, Baykara T. Modern transdermal therapeutic systems in medication. Ankara J Fac Pharm. 2008;37:145-70.